Adherence of newborn-specific antibiotic stewardship programs to CDC recommendations

Timmy Ho, Madge E. Buus-Frank, Erika M. Edwards, Kate A. Morrow, Karla Ferrelli, Arjun Srinivasan, Daniel A. Pollock, Dmitry Dukhovny, John A.F. Zupancic, De Wayne M. Pursley, Roger F. Soll, Jeffrey D. Horbar

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

BACKGROUND: The Centers for Disease Control and Prevention (CDC) published the Core Elements of Hospital Antibiotic Stewardship Programs (ASPs), while the Choosing Wisely for Newborn Medicine Top 5 list identified antibiotic therapy as an area of overuse. We identify the baseline prevalence and makeup of newborn-specific ASPs and assess the variability of NICU antibiotic use rates (AURs). METHODS: Data were collected using a cross-sectional audit of Vermont Oxford Network members in February 2016. Unit measures were derived from the 7 domains of the CDC's Core Elements of Hospital ASPs, including leadership commitment, accountability, drug expertise, action, tracking, reporting, and education. Patient-level measures included patient demographics, indications, and reasons for therapy. An AUR, defined as the number of infants who are on antibiotic therapy divided by the census that day, was calculated for each unit. RESULTS: Overall, 143 centers completed structured self-assessments. No center addressed all 7 core elements. Of the 7, only accountability (55%) and drug expertise (62%) had compliance >50%. Centers audited 4127 infants for current antibiotic exposure. There were 725 infants who received antibiotics, for a hospital median AUR of 17% (interquartile range 10%-26%). Of the 412 patients on >48 hours of antibiotics, only 26% (107 out of 412) had positive culture results. CONCLUSIONS: Significant gaps exist between CDC recommendations to improve antibiotic use and antibiotic practices during the newborn period. There is wide variation in point prevalence AURs. Three-quarters of infants who received antibiotics for >48 hours did not have infections proven by using cultures.

Original languageEnglish (US)
Article numbere20174322
JournalPediatrics
Volume142
Issue number6
DOIs
StatePublished - Dec 1 2018

Fingerprint

Centers for Disease Control and Prevention (U.S.)
Newborn Infant
Anti-Bacterial Agents
Social Responsibility
Censuses
Pharmaceutical Preparations
Compliance
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Ho, T., Buus-Frank, M. E., Edwards, E. M., Morrow, K. A., Ferrelli, K., Srinivasan, A., ... Horbar, J. D. (2018). Adherence of newborn-specific antibiotic stewardship programs to CDC recommendations. Pediatrics, 142(6), [e20174322]. https://doi.org/10.1542/peds.2017-4322

Adherence of newborn-specific antibiotic stewardship programs to CDC recommendations. / Ho, Timmy; Buus-Frank, Madge E.; Edwards, Erika M.; Morrow, Kate A.; Ferrelli, Karla; Srinivasan, Arjun; Pollock, Daniel A.; Dukhovny, Dmitry; Zupancic, John A.F.; Pursley, De Wayne M.; Soll, Roger F.; Horbar, Jeffrey D.

In: Pediatrics, Vol. 142, No. 6, e20174322, 01.12.2018.

Research output: Contribution to journalArticle

Ho, T, Buus-Frank, ME, Edwards, EM, Morrow, KA, Ferrelli, K, Srinivasan, A, Pollock, DA, Dukhovny, D, Zupancic, JAF, Pursley, DWM, Soll, RF & Horbar, JD 2018, 'Adherence of newborn-specific antibiotic stewardship programs to CDC recommendations', Pediatrics, vol. 142, no. 6, e20174322. https://doi.org/10.1542/peds.2017-4322
Ho T, Buus-Frank ME, Edwards EM, Morrow KA, Ferrelli K, Srinivasan A et al. Adherence of newborn-specific antibiotic stewardship programs to CDC recommendations. Pediatrics. 2018 Dec 1;142(6). e20174322. https://doi.org/10.1542/peds.2017-4322
Ho, Timmy ; Buus-Frank, Madge E. ; Edwards, Erika M. ; Morrow, Kate A. ; Ferrelli, Karla ; Srinivasan, Arjun ; Pollock, Daniel A. ; Dukhovny, Dmitry ; Zupancic, John A.F. ; Pursley, De Wayne M. ; Soll, Roger F. ; Horbar, Jeffrey D. / Adherence of newborn-specific antibiotic stewardship programs to CDC recommendations. In: Pediatrics. 2018 ; Vol. 142, No. 6.
@article{b6ed2e92cb69448ab98521eb1600e9fe,
title = "Adherence of newborn-specific antibiotic stewardship programs to CDC recommendations",
abstract = "BACKGROUND: The Centers for Disease Control and Prevention (CDC) published the Core Elements of Hospital Antibiotic Stewardship Programs (ASPs), while the Choosing Wisely for Newborn Medicine Top 5 list identified antibiotic therapy as an area of overuse. We identify the baseline prevalence and makeup of newborn-specific ASPs and assess the variability of NICU antibiotic use rates (AURs). METHODS: Data were collected using a cross-sectional audit of Vermont Oxford Network members in February 2016. Unit measures were derived from the 7 domains of the CDC's Core Elements of Hospital ASPs, including leadership commitment, accountability, drug expertise, action, tracking, reporting, and education. Patient-level measures included patient demographics, indications, and reasons for therapy. An AUR, defined as the number of infants who are on antibiotic therapy divided by the census that day, was calculated for each unit. RESULTS: Overall, 143 centers completed structured self-assessments. No center addressed all 7 core elements. Of the 7, only accountability (55{\%}) and drug expertise (62{\%}) had compliance >50{\%}. Centers audited 4127 infants for current antibiotic exposure. There were 725 infants who received antibiotics, for a hospital median AUR of 17{\%} (interquartile range 10{\%}-26{\%}). Of the 412 patients on >48 hours of antibiotics, only 26{\%} (107 out of 412) had positive culture results. CONCLUSIONS: Significant gaps exist between CDC recommendations to improve antibiotic use and antibiotic practices during the newborn period. There is wide variation in point prevalence AURs. Three-quarters of infants who received antibiotics for >48 hours did not have infections proven by using cultures.",
author = "Timmy Ho and Buus-Frank, {Madge E.} and Edwards, {Erika M.} and Morrow, {Kate A.} and Karla Ferrelli and Arjun Srinivasan and Pollock, {Daniel A.} and Dmitry Dukhovny and Zupancic, {John A.F.} and Pursley, {De Wayne M.} and Soll, {Roger F.} and Horbar, {Jeffrey D.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1542/peds.2017-4322",
language = "English (US)",
volume = "142",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "6",

}

TY - JOUR

T1 - Adherence of newborn-specific antibiotic stewardship programs to CDC recommendations

AU - Ho, Timmy

AU - Buus-Frank, Madge E.

AU - Edwards, Erika M.

AU - Morrow, Kate A.

AU - Ferrelli, Karla

AU - Srinivasan, Arjun

AU - Pollock, Daniel A.

AU - Dukhovny, Dmitry

AU - Zupancic, John A.F.

AU - Pursley, De Wayne M.

AU - Soll, Roger F.

AU - Horbar, Jeffrey D.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - BACKGROUND: The Centers for Disease Control and Prevention (CDC) published the Core Elements of Hospital Antibiotic Stewardship Programs (ASPs), while the Choosing Wisely for Newborn Medicine Top 5 list identified antibiotic therapy as an area of overuse. We identify the baseline prevalence and makeup of newborn-specific ASPs and assess the variability of NICU antibiotic use rates (AURs). METHODS: Data were collected using a cross-sectional audit of Vermont Oxford Network members in February 2016. Unit measures were derived from the 7 domains of the CDC's Core Elements of Hospital ASPs, including leadership commitment, accountability, drug expertise, action, tracking, reporting, and education. Patient-level measures included patient demographics, indications, and reasons for therapy. An AUR, defined as the number of infants who are on antibiotic therapy divided by the census that day, was calculated for each unit. RESULTS: Overall, 143 centers completed structured self-assessments. No center addressed all 7 core elements. Of the 7, only accountability (55%) and drug expertise (62%) had compliance >50%. Centers audited 4127 infants for current antibiotic exposure. There were 725 infants who received antibiotics, for a hospital median AUR of 17% (interquartile range 10%-26%). Of the 412 patients on >48 hours of antibiotics, only 26% (107 out of 412) had positive culture results. CONCLUSIONS: Significant gaps exist between CDC recommendations to improve antibiotic use and antibiotic practices during the newborn period. There is wide variation in point prevalence AURs. Three-quarters of infants who received antibiotics for >48 hours did not have infections proven by using cultures.

AB - BACKGROUND: The Centers for Disease Control and Prevention (CDC) published the Core Elements of Hospital Antibiotic Stewardship Programs (ASPs), while the Choosing Wisely for Newborn Medicine Top 5 list identified antibiotic therapy as an area of overuse. We identify the baseline prevalence and makeup of newborn-specific ASPs and assess the variability of NICU antibiotic use rates (AURs). METHODS: Data were collected using a cross-sectional audit of Vermont Oxford Network members in February 2016. Unit measures were derived from the 7 domains of the CDC's Core Elements of Hospital ASPs, including leadership commitment, accountability, drug expertise, action, tracking, reporting, and education. Patient-level measures included patient demographics, indications, and reasons for therapy. An AUR, defined as the number of infants who are on antibiotic therapy divided by the census that day, was calculated for each unit. RESULTS: Overall, 143 centers completed structured self-assessments. No center addressed all 7 core elements. Of the 7, only accountability (55%) and drug expertise (62%) had compliance >50%. Centers audited 4127 infants for current antibiotic exposure. There were 725 infants who received antibiotics, for a hospital median AUR of 17% (interquartile range 10%-26%). Of the 412 patients on >48 hours of antibiotics, only 26% (107 out of 412) had positive culture results. CONCLUSIONS: Significant gaps exist between CDC recommendations to improve antibiotic use and antibiotic practices during the newborn period. There is wide variation in point prevalence AURs. Three-quarters of infants who received antibiotics for >48 hours did not have infections proven by using cultures.

UR - http://www.scopus.com/inward/record.url?scp=85057852933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057852933&partnerID=8YFLogxK

U2 - 10.1542/peds.2017-4322

DO - 10.1542/peds.2017-4322

M3 - Article

VL - 142

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 6

M1 - e20174322

ER -